Skip to content

The efficacy and safety of Qinxian Zhiyang Tablets combined with ebastine in the treatment of atopic dermatitis

The efficacy and safety of Qinxian Zhiyang Tablets combined with ebastine in the treatment of atopic dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001536
Enrollment
Unknown
Registered
2025-08-05
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

Observation Group:Ebastine + Qinxian Anti-Itch Tablets

Sponsors

Hubei Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) It meets the above-mentioned diagnostic criteria of both traditional Chinese medicine and Western medicine (2) Age >18 years old; (3) No antihistamines glucocorticoids traditional Chinese medicine or other drugs for atopic dermatitis have been taken in the past four weeks. (4) Voluntarily sign the informed consent form and strictly follow the doctor's advice for treatment and follow-up visits.

Exclusion criteria

Exclusion criteria: (1) Severe abnormalities in liver and kidney functions as well as blood system functions; (2) Pregnant or lactating women; (3) Currently participating in other research on atopic dermatitis;

Design outcomes

Primary

MeasureTime frame
Scoring Atopic Dermatitis;

Secondary

MeasureTime frame
dermatology life quality index;Laboratory indicators (EOS, IL-6, TNF-a, IL-1ß, IgE, D-D, VitD); TCM Pattern Identification Questionnaire;visual analogue scale; Safety Observation Indicators (blood routine , liver and kidney function adverse event records);

Countries

China

Contacts

Public ContactZhu Junrong

Hubei Provincial Hospital of Traditional Chinese Medicine

973000319@qq.com+86 156 7155 1819

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026